🔎 Trials Near Me

Hem › Astma › Colorado

Kliniska studier för Astma i Colorado

18 studier för Astma söker deltagare vid platser i Colorado.

Städer i Colorado

Officiell studietext (engelska)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Colorado Springs
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 30 sep. 2026 · NCT05757102

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, Colorado Springs
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 24 sep. 2026 · NCT07301255

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  • Research Site, Aurora
RekryterarFas 3
Ålder 6 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07444567

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  • Asthma & Allergy Associates - Colorado Springs, Colorado Springs
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07219173

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Colorado ENT & Allergy, Colorado Springs
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06977581

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  • Research Site 15, Colorado Springs
RekryterarFas 3
Ålder 12 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07276724

PULmonary Stimulation for Asthma Relief

  • National Jewish Health, Denver
Rekryterar
Ålder 18 till 75 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07709754

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • Teva Investigational Site 12142, Lakewood
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 31 aug. 2026 · NCT06664619

A Study of Depemokimab in Participants of 6 to 11 Years of Age

  • GSK Investigational Site, Colorado Springs
RekryterarFas 3
Ålder 6 till 11 · Alla kön · Uppdaterad 26 aug. 2026 · NCT07671001

Registry of Asthma Characterization and Recruitment 3 (RACR3)

  • Children's Hospital Colorado: Allergy Program, Aurora
RekryterarObservationsstudieFriska volontärer välkomna
Alla åldrar · Alla kön · Uppdaterad 21 aug. 2026 · NCT05272241

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  • GSK Investigational Site, Aurora
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT07456033

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Denver
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 13 aug. 2026 · NCT06307665

Protocol CAUSE-03 / CHEETAH

  • Children's Hospital Colorado: Allergy Program, Aurora
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 6 till 17 · Alla kön · Uppdaterad 1 juli 2026 · NCT06136091

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • DARTNet Institute, Aurora
  • University Colorado-Denver, Aurora
RekryterarFas 4
Ålder 13 till 75 · Alla kön · Uppdaterad 29 okt. 2025 · NCT07052942

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

  • University of Colorado Anschutz Medical Campus, Aurora
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 10 juni 2025 · NCT03762395

Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation

  • National Jewish Health, Denver
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 6 apr. 2023 · NCT05259904

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

  • University of Colorado, Aurora
Rekryterar
Ålder 18 till 65 · Alla kön · Uppdaterad 2 feb. 2023 · NCT03215836

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

  • National Jewish Health, Denver
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2017 · NCT02947945

Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.